|
Endocyte Inc.
company
|
Overview
Endocyte is developing drug targeting systems to improve the safety and efficacy of therapeutics by targeting them to diseased cells. Endocyte's lead receptor-targeting technology uses the vitamin Folate to target cancer cells.
Financial Information
Areas of Expertise
Technologies involved in:
Drug targeting,
Drug delivery,
In Vivo Imaging,
Molecular imaging,
Personalized medicine,
add other
Medical focus:
Cancer, Prostate cancer
Corporate Information
| Webpage |
|
| Headquarters |
|
| Industries |
|
Products
Therapeutics on the Market
| Product |
Developed By |
2007 Sales ($M) |
2006 Sales ($M) |
2005 Sales ($M) |
Indications / Phase of Development |
Products on the Market
| Product Brand |
Name |
Developed By |
2007 Sales ($M) |
Therapeutics in Development
| Product |
Developed By |
Indications / Phase of Development |
Products in Development
| Product |
Brand Name |
Overview |
